Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Aliment Pharmacol Ther. 2017 Dec 15;47(4):494–503. doi: 10.1111/apt.14471

Figure 1.

Figure 1

Association of prediagnostic and 3-year follow-up measurement of serum pepsinogen I and subsequent gastric cancer risk in the ATBC Study

Abbreviations: ATBC – Alpha-Tocopherol, Beta-Carotene Cancer Prevention, f/u – follow-up, OR – odds ratio, CI – confidence interval, SPGI - Serum pepsinogen I,

Group A: H. pylori (−) and normal SPGI, Group B: H. pylori (+) and normal SPGI, Group C: H. pylori (+) and low SPGI, Group D: H. pylori (−) and low SPGI

Model adjusted for age at randomization, type of intervention, pack years of smoking, alcohol drinking, education, fruit intake, vegetable intake

* Numbers in parentheses indicate gastric cancer cases in each group at follow-up

Cases diagnosed before follow-up measurements (≤3 years) were excluded from the analysis (n=5)